Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
dotScribe
AddedFeb 18, 2024
UpdatedJun 18, 2026
dotScribe

dotScribe

Seed

dotScribe: AI-powered SaaS enhancing medical productivity through time-saving, simplified charting.

HQ
Scottsdale, AZ, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to enhance medical productivity, dotScribe offers an AI-powered SaaS designed to save time and simplify the practice of medicine. The platform provides medical practitioners with real-time suggestions, templates, and diagnostic tools while they chart, making it EHR-independent and versatile across various desktop applications. dotScribe aims to streamline medical documentation and decision-making processes, catering primarily to medical students, residents, and clinicians.

Notable figures associated with dotScribe include experts in both the medical and technology fields, though specific names are not provided. The company has achieved significant milestones, including the successful deployment of its AI assistant across multiple EHR systems and desktop applications. By improving efficiency and accuracy in medical documentation, dotScribe is making a substantial impact on healthcare delivery, ultimately aiming to reduce burnout and enhance patient care.

dotScribe - Similar Companies

DeepScribe logo

DeepScribe

deepscribe.tech

Barton's Brain logo

Barton's Brain

ScribeLink logo

ScribeLink

scribelink.com

Phraze logo

Phraze

phraze.co

Brevi logo

Brevi

brevi.tech

Sopris Health logo

Sopris Health

soprishealth.com

iScribeHealth logo

iScribeHealth

iscribehealth.com

Ambience Healthcare logo

Ambience Healthcare

Doctible logo

Doctible

doctible.com

DocBuddy logo

DocBuddy

docbuddy.com

Vocalto logo

Vocalto

Hippo Scribe logo

Hippo Scribe

gethipposcribe.com

Regard logo

Regard

withregard.com

Knowtex logo

Knowtex

knowtex.ai

Emergency Medicine Scribe Systems logo

Emergency Medicine Scribe Systems

dotScribe - Quick Facts

Who are dotScribe's competitors?

Companies similar to dotScribe include DeepScribe, Barton's Brain, ScribeLink and Phraze.

When was dotScribe founded?

dotScribe was founded in 2020.

Where is dotScribe's headquarters located?

dotScribe's headquarters is located in Scottsdale, AZ, US.

When was dotScribe's last funding round?

dotScribe's most recent funding round was for $60k (USD) in January 2022.

How much has dotScribe raised to-date?

As of Jan 1, 2022, dotScribe has raised a total of $240k (USD).

How many employees does dotScribe have?

dotScribe has 2 employees as of Feb 4, 2024.

dotScribe - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Medical Software
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified